Press release
Investigation announced for Investors in shares of Axcella Health Inc. (NASDAQ: AXLA)
An investigation for investors in Axcella Health Inc. (NASDAQ: AXLA) shares over potential securities laws violations by Axcella.
Investors who purchased shares of Axcella Health Inc. (NASDAQ: AXLA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Axcella Health Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Cambirdge, MA based Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. Axcella Health Inc. went public in May 2019 and sold over 3.5 million shares at $20 per share in the initial public offering (“IPO”). Since then, shares of Axcella Health Inc. (NASDAQ: AXLA) declined to as low as $4.99 per share on October 7, 2019.
On October 22, 2019, NASDAQ: AXLA shares closed at $5.25 per share.
Those who purchased shares of Axcella Health Inc. (NASDAQ: AXLA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Axcella Health Inc. (NASDAQ: AXLA) here
News-ID: 1855710 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Axcella
Overt Hepatic Encephalopathy Market to Observe Stunning Growth by 2032, Evaluate …
DelveInsight's "Overt Hepatic Encephalopathy Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Overt Hepatic Encephalopathy Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Overt Hepatic Encephalopathy market report covers emerging drugs, treatment practices, market share of the individual therapies, and current &…
Nucleic Acid Therapeutics Market Global Scenario, Market Size, Outlook, Trend, a …
“The global nucleic acid therapeutics market is predicted to surpass the market size of US$ 9 Billion by 2028; registering a CAGR of 19.5% during the forecast period from 2021- 2028”, Says Accurize Market Research.
Increased attention towards the usage of nucleic acid-based therapeutics has gained momentum owing to its ability to treat chronic illnesses. Numerous types of diseases such as cancer, tuberculosis, AIDS, diabetes, and cardiovascular diseases can be treated…
Nucleic Acid-Based Therapeutics Market Outlook and Deep Study of Top Key Players …
Databridgemarketresearch.com Present “Nucleic Acid-Based Therapeutics Market– Industry Trends and Forecast to 2027” new report to its research database. The report first introduces the market basics like definitions, classifications, applications and industry chain overview, and then industry policies and plans, product specifications, manufacturing processes, cost structures and so on. The report highlights the change in the market which is taking place due to the moves of key players and brands such…
